Investors
We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.
Second Quarter 2026 Results
Second quarter 2026 results were reviewed by management during a live audio webcast with the financial community on July 30, 2026. The presentation was followed by a Q&A session.
Press Releases
Upcoming Events
12Aug
TD Cowen’s Hot Wheels 2026 Tour – Morristown, NJ
Speakers:
Burcu Eryilmaz - Global Head of Rare Diseases Franchise
Alyssa Johnsen - SVP, Therapeutic Area Head, Development, Immunology and Inflammation
Karin Knobe - Therapeutic Area Head Rare Diseases
Conferences
2Sep
Jefferies Swiss Healthcare Seminar - Zurich
Conferences
3Sep
Citi’s European Pharma Bus Tour – Paris
Conferences
Dividend (in dollars) per ADR (½ share)
Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
Contact Our Investor Relations Team
For general inquiries
Please contact the switchboard, +33 (0)1 53 77 40 00